34
Participants
Start Date
August 31, 2009
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2012
Imatinib mesylate
Imatinib (Gleevec) 600 mg/day, oral administration in 4-day pulses(days 1-4; 8-11; 15-18) Cycle length: 28 days Number of cycles: up to 6
Paclitaxel
Paclitaxel 90 mg/m2 IV on days 3, 10, 17 Cycle length: 28 days Number of cycles: up to 6
University of New Mexico Cancer Center @ Lovelace Medical Center, Albuquerque
University of New Mexico Cancer Center, Albuquerque
Univ. of Washington Fred Hutchinson Cancer Research Center (UW-FHCRC), Seattle
Collaborators (1)
Fred Hutchinson Cancer Center
OTHER
Novartis
INDUSTRY
New Mexico Cancer Research Alliance
OTHER